Advertisement
Screener

NANOVIRICIDES, INC. (NNVC) Payments for Advance to Affiliate

NANOVIRICIDES, INC. Payments for Advance to Affiliate

NANOVIRICIDES, INC. (NNVC) reported Payments for Advance to Affiliate of -$1.00 million for the 12-month period ending 2015-06-30, per its 10-K filed 2015-09-14.

Discontinued › Cash Flow › Financing Activities

us-gaap:PaymentsForAdvanceToAffiliate · last filed 2015-09-14

  • NANOVIRICIDES, INC. payments for advance to affiliate for the quarter ending 2015-06-30 was $0.00.
  • NANOVIRICIDES, INC. payments for advance to affiliate for the quarter ending 2015-03-31 was -$1.00M.
  • NANOVIRICIDES, INC. payments for advance to affiliate for the quarter ending 2014-12-31 was $0.00.
  • NANOVIRICIDES, INC. payments for advance to affiliate for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
  • NANOVIRICIDES, INC. payments for advance to affiliate for fiscal 2015 was -$1.00M.
  • NANOVIRICIDES, INC. payments for advance to affiliate for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
  • NANOVIRICIDES, INC. payments for advance to affiliate for fiscal 2013 was $1.00M.
  • NANOVIRICIDES, INC. payments for advance to affiliate for fiscal 2012 was $0.00.
Period endPayments for Advance to Affiliate 3 monthPayments for Advance to Affiliate 6 monthPayments for Advance to Affiliate 9 monthPayments for Advance to Affiliate 12 monthPayments for Advance to Affiliate 95 monthPayments for Advance to Affiliate 99 monthPayments for Advance to Affiliate 101 monthPayments for Advance to Affiliate 104 monthPayments for Advance to Affiliate 107 month
2015-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-14
-$1.00M
derived: sum of 2 quarters · filed 2015-09-14
-$1.00M
derived: sum of 3 quarters · filed 2015-09-14
-$1.00M
10-K · filed 2015-09-14
2015-03-31-$1.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15
-$1.00M
derived: sum of 2 quarters · filed 2015-05-15
-$1.00M
10-Q · filed 2015-05-15
-$2.00M
derived: sum of 4 quarters · filed 2015-09-14
2014-12-31$0.00
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-02-25
$0.00
10-Q · filed 2015-02-25
-$1.00M
derived: sum of 3 quarters · filed 2015-09-14
-$1.00M
derived: sum of 4 quarters · filed 2015-09-14
2014-09-30$0.00
10-Q/A · filed 2015-02-23
-$1.00M
derived: sum of 2 quarters · filed 2015-09-14
-$1.00M
derived: sum of 3 quarters · filed 2015-09-14
-$1.00M
derived: sum of 4 quarters · filed 2015-09-14
2014-06-30-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-14
-$1.00M
derived: sum of 2 quarters · filed 2015-09-14
-$1.00M
derived: sum of 3 quarters · filed 2015-09-14
$0.00
10-K · filed 2015-09-14
2014-03-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15
$0.00
derived: sum of 2 quarters · filed 2015-05-15
$1.00M
10-Q · filed 2015-05-15
$1.00M
derived: sum of 4 quarters · filed 2015-09-14
$2.00M
10-Q · filed 2014-05-15
2013-12-31$0.00
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-02-25
$1.00M
10-Q · filed 2015-02-25
$1.00M
derived: sum of 3 quarters · filed 2015-09-14
$2.00M
derived: sum of 4 quarters · filed 2015-09-14
$2.00M
10-Q · filed 2014-02-14
2013-09-30$1.00M
10-Q/A · filed 2015-02-23
$1.00M
derived: sum of 2 quarters · filed 2015-09-14
$2.00M
derived: sum of 3 quarters · filed 2015-09-14
$2.00M
10-Q/A · filed 2013-11-18
2013-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-14
$1.00M
derived: sum of 2 quarters · filed 2015-09-14
$1.00M
10-K · filed 2015-09-14
$1.00M
10-K/A · filed 2013-10-08
2013-03-31$1.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-15
$1.00M
10-Q · filed 2014-05-15
$1.00M
10-Q/A · filed 2013-05-20
2012-12-31$0.00
10-Q · filed 2014-02-14
2012-06-30$0.00
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2013-10-08
$0.00
10-K/A · filed 2013-10-08
2012-03-31$0.00
10-Q/A · filed 2013-05-20
2011-06-30$0.00
10-K/A · filed 2013-10-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
BeyondSpring Inc. (BYSI)United States$0.031B-10.95
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30